In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

FDA OTC Labeling Final Rule Based On "Unrealistic Assumptions" - CHPA

This article was originally published in The Tan Sheet

Executive Summary

FDA's final rule on OTC labeling "appears to be based on unrealistic assumptions," Consumer Healthcare Products Association Senior VP and Director of Science & Technology William Soller, PhD, asserted at an FDA "feedback" meeting April 23. "A number of examples used by FDA" as samples of OTC labels "are unrealistic projections of actual labeling," Soller added.

You may also be interested in...



Trade Dress Uniqueness Restricted By OTC Labeling Rule, CTFA Argues

FDA's OTC labeling final rule limits the number of options companies have to distinguish their products on retail shelves, Cosmetic, Toiletry & Fragrance Association VP-Legal & General Counsel Thomas Donegan maintained during a "feedback" meeting with the agency in Rockville, Md. June 29.

OTC Label Multiple Columns Suggested For Elongated Packaging By CHPA

FDA should allow the use of more than two columns to present required information on OTC labeling for products with long rectangular packaging, Consumer Healthcare Products Association Senior VP and Director of Science & Technology William Soller, PhD, said at a "feedback" meeting on the OTC labeling final rule in Rockville, Md. June 29.

Trade Dress Uniqueness Restricted By OTC Labeling Rule, CTFA Argues

FDA's OTC labeling final rule limits the number of options companies have to distinguish their products on retail shelves, Cosmetic, Toiletry & Fragrance Association VP-Legal & General Counsel Thomas Donegan maintained during a "feedback" meeting with the agency in Rockville, Md. June 29.

Related Content

Topics

UsernamePublicRestriction

Register

PS089704

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel